Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Cogent Biosciences, Inc. - Common Stock (NQ:COGT)

37.00 -0.25 (-0.67%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 20, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,160,296
Open	37.48
Bid (Size)	37.00 (10,000)
Ask (Size)	37.97 (200)
Prev. Close	37.25
Today's Range	36.74 - 37.99
52wk Range	4.200 - 43.73
Shares Outstanding	85,465,249
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Great Rotation of 2026: Why Small Caps are Finally Dethroning the Tech Giants

March 27, 2026

The financial landscape of 2026 has been defined by a seismic shift in capital allocation that few analysts predicted with such intensity. For the first time in over a decade, the long-dormant Russell...

Via MarketMinute

The Great Rotation: Small-Caps Seize Market Leadership in Historic 2026 Breakout

March 25, 2026

The financial landscape has undergone a tectonic shift in the opening months of 2026, as the long-dormant Russell 2000 index has surged to record highs, marking what many analysts believe is the...

Via MarketMinute

Performance

YTD	+6.5%	+6.5%
1 Month	+10.8%	+10.8%
3 Month	-7.3%	-7.3%
6 Month	+128.1%	+128.1%
1 Year	+760.5%	+760.5%

More News

This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch ↗

March 21, 2026

Via The Motley Fool

High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding ↗

March 21, 2026

Via The Motley Fool

This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know ↗

March 21, 2026

Via The Motley Fool

This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know ↗

March 21, 2026

Via The Motley Fool

Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish ↗

March 21, 2026

Via The Motley Fool

Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗

March 20, 2026

Via The Motley Fool

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain ↗

March 18, 2026

Via The Motley Fool

Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? ↗

March 18, 2026

Via The Motley Fool

This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names ↗

March 18, 2026

Via The Motley Fool

This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish ↗

March 18, 2026

Via The Motley Fool

This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗

March 13, 2026

Via The Motley Fool

Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗

March 13, 2026

Via The Motley Fool

Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline ↗

March 13, 2026

Via The Motley Fool

Biotech Stock Up 365% as This $8 Million Investment Targets a Drug With 3 NDA Filings Planned ↗

March 13, 2026

Via The Motley Fool

The Small-Cap Renaissance: Russell 2000 Eclipses Big Tech in Historic Early 2026 Surge

March 12, 2026

Via MarketMinute

Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗

February 17, 2026

Via The Motley Fool

Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗

February 17, 2026

Via The Motley Fool

Large Biotech Fund Sells Shares of Cogent Biosciences for Over $120M ↗

February 01, 2026

Via The Motley Fool

Cogent Insider Sells $2.5 Million in Stock Amid Staggering 300% Price Surge ↗

January 11, 2026

Via The Motley Fool

What's going on in today's after hours session ↗

December 30, 2025

Via Chartmill

This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗

December 09, 2025

Via The Motley Fool

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗

December 09, 2025

Via The Motley Fool

Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗

December 09, 2025

Via The Motley Fool

Frequently Asked Questions

Is Cogent Biosciences, Inc. - Common Stock publicly traded?

Yes, Cogent Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Cogent Biosciences, Inc. - Common Stock trade on?

Cogent Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Cogent Biosciences, Inc. - Common Stock?

The ticker symbol for Cogent Biosciences, Inc. - Common Stock is COGT on the Nasdaq Stock Market

What is the current price of Cogent Biosciences, Inc. - Common Stock?

The current price of Cogent Biosciences, Inc. - Common Stock is 37.00

When was Cogent Biosciences, Inc. - Common Stock last traded?

The last trade of Cogent Biosciences, Inc. - Common Stock was at 04/20/26 04:00 PM ET

What is the market capitalization of Cogent Biosciences, Inc. - Common Stock?

The market capitalization of Cogent Biosciences, Inc. - Common Stock is 3.16B

How many shares of Cogent Biosciences, Inc. - Common Stock are outstanding?

Cogent Biosciences, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.